ArticleMolecular biology reports2025
NLRP1 gene polymorphism rs2670660 is associated with vitiligo in the Pakistani population.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cytokine and Inflammasome Gene Polymorphisms in Vitiligo: A Candidate-Polymorphism Meta-Analysis.The Australasian journal of dermatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe most prevalent type of acquired depigmentation disorder is vitiligo, which is characterized by the development of white spots on the skin, hair, and mucous membranes due to melanocyte loss. It is a polygenic and multifactorial disease with complicated genetic and environmental pathogenesis. The onset and progression of vitiligo are strongly influenced by both genetic and environmental variables, including neurological effects, oxidative-antioxidative stress, and immune dysfunction. METHODS AND
resultsThe polymorphism (rs2670660) in the NLRP1 gene was analyzed in 110 patients with vitiligo and 110 healthy controls matched for age and sex. Tetra-ARMS PCR was used to determine the genotypes, and Sanger sequencing was employed to validate the three genotypes. Initial genotype analysis revealed significant differences in genotype distribution between cases and control (p = 0.035). Further analysis of the genotype data showed that the frequency of the GG genotypes was significantly higher in vitiligo cases than in controls under the recessive model (odds ratio [OR] 2.647; 95% confidence interval [CI] 1.230-5.695; p-value = 0.011). Moreover, the prevalence of the G allele was also significantly higher in the patient group (P = 0.019, OR = 1.595, 95% CI = 1.081-2.353).
conclusionIn conclusion, the NLRP1 polymorphism rs2670660 is significantly associated with the onset of vitiligo in the Pakistani population.
Indexed as
Identifiers
41396559What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.